COVID-19 vaccines Vaccine safety data Main navigation COVID-19 vaccines Pfizer LP.8.1 COVID-19 vaccine safety data – all participants Pfizer JN.1 COVID-19 vaccine safety data – all participants Pfizer XBB.1.5 COVID-19 vaccine Pfizer COVID-19 vaccine paediatric formulation (5–11 years) Moderna XBB.1.5 COVID-19 vaccine Pfizer bivalent BA.4/5 COVID-19 vaccine Moderna bivalent COVID-19 vaccine Pfizer bivalent BA.1 COVID-19 vaccine Pfizer COVID-19 vaccine adult formulation Moderna COVID-19 vaccine Novavax COVID-19 vaccine AstraZeneca COVID-19 vaccine Influenza vaccines Mpox (monkeypox) vaccine National Immunisation Program schedule vaccines Nirsevimab RSV vaccines Vaccine safety in Australia AusVaxSafety summary reports AusVaxSafety is conducting active vaccine safety surveillance of the COVID-19 vaccines in use in Australia to ensure their ongoing safety.Latest monthly COVID-19 vaccine safety dataClick on the tiles below to view AusVaxSafety COVID-19 vaccine safety data for specific population groups. Pfizer LP.8.1 COVID-19 vaccine safety data – all participants View the latest Pfizer LP.8.1 COVID-19 vaccine safety data here Pfizer JN.1 COVID-19 vaccine safety data – all participants View the latest Pfizer JN.1 COVID-19 vaccine safety data here Pfizer monovalent Omicron XBB.1.5 COVID-19 vaccine safety data – all participants View the latest Pfizer XBB.1.5 COVID-19 vaccine safety data here Pfizer paediatric (5–11 years) COVID-19 vaccine safety data – child participants View the latest Pfizer paediatric (5–11 years) COVID-19 vaccine safety data here Moderna monovalent Omicron XBB.1.5 COVID-19 vaccine safety data – all participants View the latest Moderna XBB.1.5 COVID-19 vaccine safety data here Pfizer bivalent BA.4/5- COVID-19 vaccine View the latest Pfizer bivalent BA.4/5 COVID-19 vaccine safety data here Moderna bivalent COVID-19 vaccine View the latest Moderna bivalent COVID-19 vaccine safety data here Pfizer bivalent BA.1 COVID-19 vaccine View the latest Pfizer bivalent BA.1 COVID-19 vaccine safety data here Pfizer COVID-19 vaccine adult formulation View the latest safety data for Pfizer COVID-19 vaccine adult formulation here Moderna COVID-19 vaccine View the latest Moderna COVID-19 vaccine safety data here Novavax COVID-19 vaccine View the latest Novavax COVID-19 vaccine safety data here AstraZeneca COVID-19 vaccine View the latest AstraZeneca COVID-19 vaccine safety data here Vaccine safety data Main navigation COVID-19 vaccines Pfizer LP.8.1 COVID-19 vaccine safety data – all participants Pfizer JN.1 COVID-19 vaccine safety data – all participants Pfizer XBB.1.5 COVID-19 vaccine Pfizer COVID-19 vaccine paediatric formulation (5–11 years) Moderna XBB.1.5 COVID-19 vaccine Pfizer bivalent BA.4/5 COVID-19 vaccine Moderna bivalent COVID-19 vaccine Pfizer bivalent BA.1 COVID-19 vaccine Pfizer COVID-19 vaccine adult formulation Moderna COVID-19 vaccine Novavax COVID-19 vaccine AstraZeneca COVID-19 vaccine Influenza vaccines Mpox (monkeypox) vaccine National Immunisation Program schedule vaccines Nirsevimab RSV vaccines Vaccine safety in Australia AusVaxSafety summary reports News & events All news & events 02 April 2026 | News AusVaxSafety begins surveillance of 2026 influenza vaccines, including new nasal spray option 05 March 2026 | News New LP.8.1 COVID-19 vaccines well tolerated, new AusVaxSafety data show 14 July 2025 | News Fewer adverse events reported following NIP pneumococcal vaccine change 03 June 2025 | News New AusVaxSafety data confirms Abrysvo RSV vaccine is well tolerated during pregnancy; adverse events comparable to other maternal vaccinations